Drugs (Pharmaceuticals) – Page 43

Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles

The Food and Drug Administration is expected this week to allow the overdose-reversal medication to be sold without a prescription, a step toward making it a common emergency tool.

By Jan Hoffman

California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.

By Benjamin Ryan

Drugs (Pharmaceuticals) Food and Drug Administration Hospitals Peters, Gary Prices (Fares, Fees and Rates) Senate Committee on Homeland Security and Governmental Affairs Shortages Supply Chain United States Politics and Government

Rising Rate of Drug Shortages Is Framed as a National Security Threat

A Senate homeland security committee examined growing health care shortages amid reports of rationing within hospitals.

By Christina Jewett

Diabetes Drugs (Pharmaceuticals) Eli Lilly and Company Health Insurance and Managed Care Insulin Novo Nordisk A/S Prices (Fares, Fees and Rates) Sanofi SA

Sanofi Plans to Cut the Price of Insulin

The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.

By Rebecca Robbins

mosaec